Background illustration for clinical trials search

Paid Clinical Trials Hartford

Discover 1,108 paid clinical trials in Hartford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Interoceptive Awareness and Function in Adolescents With Chronic Pain

for
Chronic Pain, Chronic Pain Syndrome, Pain, Chronic
Location: Hartford CT
Sponsor: Connecticut Children's Medical Center

Sex: All

Age: 11 - 21

Code: NCT07325110

Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Hartford CT, Springfield MA, New Haven CT,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

for
IBD, Crohn Disease (CD), Ulcerative Colitis (UC),
Location: Hartford CT
Sponsor: Connecticut Children's Medical Center

Sex: All

Age: 10 - 21

Code: NCT07224113

Recruiting

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

for
Atypical Teratoid/Rhabdoid Tumor,
Location: Hartford CT, Hackensack NJ, Hershey PA, Nashville TN,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 26

Code: NCT06465199

Phase1, Phase2, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Hartford CT, Worcester MA, Providence RI, Albany NY,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

for
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Location: Hartford CT, Boston MA, Philadelphia PA, Baltimore MD,
Sponsor: University of Iowa

Sex: All

Age: 0+

Code: NCT01193088

Recruiting

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

for
Charcot Marie Tooth Disease
Location: Hartford CT, Boston MA, Philadelphia PA, Baltimore MD,
Sponsor: Michael Shy

Sex: All

Age: 0+

Code: NCT01193075

Recruiting

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

for
Colitis, Ulcerative
Location: Hartford CT, Carmel NY, Providence RI, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 12+

Code: NCT07196748

Phase3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Hartford CT, New Haven CT, Stony Brook NY,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Hartford CT, Stony Brook NY, Providence RI, Albany NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase2, Recruiting

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

for
Malignant Glioma
Location: Hartford CT, New Haven CT, Providence RI, Albany NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 21

Code: NCT05099003

Phase1, Phase2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Hartford CT, New Haven CT, Worcester MA, Stony Brook NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Hartford CT, New Haven CT, Albany NY, The Bronx NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase2, Recruiting

Echography-guided Surfactant THERapy (ESTHER) For Preterm Infants With Respiratory Failure

for
Respiratory Distress Syndrome, Newborn, Pulmonary Surfactants,
Location: Hartford CT
Sponsor: Connecticut Children's Medical Center

Sex: All

Age: 0

Code: NCT06446453

Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Hartford CT, Albany NY, The Bronx NY, Boston MA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase2, Recruiting

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

for
Rheumatic Joint Disease
Location: Hartford CT, Providence RI, Albany NY, New York NY,
Sponsor: Duke University

Sex: All

Age: 0 - 21

Code: NCT02418442

Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

for
Hematologic Disorder, Bleeding Disorder,
Location: Hartford CT, New Haven CT, Providence RI, The Bronx NY,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 0+

Code: NCT04398628

Recruiting

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

for
Crohn's Disease
Location: Hartford CT, New York NY, Philadelphia PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 2 - 17

Code: NCT05509777

Phase3, Recruiting

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

for
Neuroblastoma
Location: Hartford CT, Hershey PA, Sherbrooke, Montreal, Quebec,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 22

Code: NCT02559778

Phase2, Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Hartford CT, New Haven CT, Providence RI, Valhalla NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase3, Recruiting